Curated Collections
Explore our themed educational resources and build your knowledge of genomics in healthcare
Circulating Tumour DNA (ctDNA)
The circulating tumour DNA (ctDNA) pilot project launched in 2022 and is now in its 3rd phase. The pilot study aimed to evaluate how liquid biopsy testing could be brought into an established NHS lung cancer diagnostic pathway. Liquid biopsy tests, also known as circulating tumour DNA (ctDNA) tests, sequence fragments of tumour DNA that are released into the blood stream.
This curated collection provides resources for clinicians around reading a ctDNA report as well as providing videos to help explain the test to patients.
The contents of this video is correct at time of release, September 2024.
Download FilePPTX 20.67 MB
The contents of this video is correct at time of release, September 2024.